GB virus C infection in hemodialysis patients: Molecular evidence for nosocomial transmission

被引:14
作者
Kao, JH
Huang, CH
Chen, W
Tsai, TJ
Lee, SH
Hung, KY
Chen, DS
机构
[1] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Internal Med, Grad Inst Clin Med, Taipei 10764, Taiwan
[3] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 10764, Taiwan
[4] Shin Kong Wu Ho Su Mem Hosp, Dept Internal Med, Taipei, Taiwan
关键词
D O I
10.1086/314850
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Studies of the prevalence and clinical relevance of GB virus C (GBV-C) infection in 328 hemodialysis (HD) patients were done, and the possibility of nosocomial GBV-C transmission was explored by molecular epidemiology methods. For GBV-C viremic patients in a given HD unit, nucleotide sequences of the envelope region were analyzed by phylogenetic tree constructions. Of 328 HD patients, active hepatitis B virus, hepatitis C virus (HCV), and GBV-C infection were detected in 13%, 23%, and 17%, respectively. Except for a higher frequency of HCV coinfection, the demographic and clinical characteristics of patients with and without GBV-C infection were comparable. In contrast, patients with isolated HCV infection had significantly higher serum transaminase levels, longer time on HD, and more blood transfusions. Phylogenetic analysis showed several distinct clusters of closely related GBV-C isolates from one HD unit, suggesting the possibility of nosocomial transmission. These results suggest that GBV-C plays a minimal role in causing hepatitis in Taiwanese HD patients and in nosocomial transmission.
引用
收藏
页码:191 / 194
页数:4
相关论文
共 24 条
[1]   HGV/HGBV-C, a new virus in the dialysis setting [J].
Beccari, M .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1997, 20 (01) :12-13
[2]   Prevalence of hepatitis C and G virus infection in chronic hemodialysis patients [J].
de Medina, M ;
Ashby, M ;
Schlüter, V ;
Hill, M ;
Leclerq, B ;
Pennell, JP ;
Jeffers, LJ ;
Reddy, KR ;
Schiff, ER ;
Hess, G ;
Perez, GO .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (02) :224-226
[3]  
Kao JH, 1997, J MED VIROL, V53, P348, DOI 10.1002/(SICI)1096-9071(199712)53:4&lt
[4]  
348::AID-JMV6&gt
[5]  
3.0.CO
[6]  
2-7
[7]  
Kao JH, 1997, J MED VIROL, V51, P284, DOI 10.1002/(SICI)1096-9071(199704)51:4&lt
[8]  
284::AID-JMV5&gt
[9]  
3.0.CO
[10]  
2-1